GOLDMAN SACHS GROUP INC - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 36 filers reported holding TRACON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$42,000
-82.9%
10,755
-48.7%
0.00%
Q4 2020$246,000
+148.5%
20,984
+10.1%
0.00%
Q3 2020$99,00019,0610.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,518,371$16,344,0002.72%
Ikarian Capital, LLC 2,716,840$17,631,0001.42%
Telemetry Investments, L.L.C. 40,000$260,0000.36%
ACT CAPITAL MANAGEMENT, LLC 28,500$185,0000.10%
Vigilare Wealth Management 17,000$110,0000.07%
X-Square Capital, LLC 20,973$136,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 294,031$1,908,0000.06%
Johnson & Johnson Innovation - JJDC, Inc. 84,003$545,0000.06%
NEA Management Company, LLC 346,718$2,250,0000.03%
GSA CAPITAL PARTNERS LLP 36,370$236,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders